Variant report
Variant | nsv962385 |
---|---|
Chromosome Location | chr17:20579736-20585142 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs117976645 | chr17:20579758-20579759 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs563854353 | chr17:20579836-20579837 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs531387831 | chr17:20579847-20579848 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs549977482 | chr17:20579862-20579863 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs530005 | chr17:20579976-20579977 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs568260932 | chr17:20579979-20579980 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs529882 | chr17:20580016-20580017 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs140989187 | chr17:20580050-20580051 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs144640959 | chr17:20580054-20580055 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs529137 | chr17:20580061-20580062 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs147464779 | chr17:20580067-20580068 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs2255924 | chr17:20580088-20580089 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs558247786 | chr17:20580106-20580107 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs2779237 | chr17:20580163-20580164 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs528162 | chr17:20580186-20580187 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs569553155 | chr17:20580205-20580206 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs142893648 | chr17:20580215-20580216 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs185077963 | chr17:20580249-20580250 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs599106 | chr17:20580254-20580255 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs574163382 | chr17:20580305-20580306 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs541666601 | chr17:20580357-20580358 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs559818111 | chr17:20580472-20580473 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs151063051 | chr17:20580477-20580478 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs189491704 | chr17:20580519-20580520 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs563817596 | chr17:20580538-20580539 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs531354543 | chr17:20580570-20580571 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs115956713 | chr17:20580589-20580590 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs189678985 | chr17:20580604-20580605 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs535252947 | chr17:20580610-20580611 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs180975558 | chr17:20580612-20580613 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs529081478 | chr17:20580656-20580657 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs547638392 | chr17:20580660-20580661 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs565992472 | chr17:20580670-20580671 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs369379738 | chr17:20580689-20580690 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs551824958 | chr17:20580726-20580727 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs144076657 | chr17:20580755-20580756 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs537514550 | chr17:20580758-20580759 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs555584918 | chr17:20580774-20580775 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs574153205 | chr17:20580796-20580797 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs534922692 | chr17:20580808-20580809 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs553235849 | chr17:20580887-20580888 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs596008 | chr17:20580901-20580902 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs185149822 | chr17:20580909-20580910 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs557371041 | chr17:20580935-20580936 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs375814523 | chr17:20580938-20580939 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs595899 | chr17:20580969-20580970 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs188042375 | chr17:20580976-20580977 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs111644151 | chr17:20581023-20581024 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
49 | rs529047148 | chr17:20581043-20581044 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs144857535 | chr17:20581047-20581048 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Chordoma | 21602918 | CNVD |
Miller-Dieker syndrome | 22283845 | CNVD |
Non-syndromic sensorineural hearing loss | 17457615 | CNVD |
Cancer | 22429812 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Breast cancer | 22028636 | CNVD |
Breast cancer | 20837533 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
colon cancer | 17210682 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Chronic lymphocytic leukemia | 17971485 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Breast cancer | 16461572 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 17133270 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Moyamoya disease | 22323933 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20724749 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Colorectal cancer | 21645411 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
HIV/AIDS | 17953491 | CNVD |
HIV/AIDS | 20877625 | CNVD |
Immune disease | 21076436 | CNVD |
Rheumatoid arthritis | 17953491 | CNVD |
Type 1 diabetes | 17953491 | CNVD |
HIV/AIDS | 15637236 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Neurofibromatosis | 18196300 | CNVD |
Breast cancer | 17001317 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Charcot-marie-tooth disease | 16463004 | CNVD |
Osteosarcoma | 22292074 | CNVD |
Breast cancer | 17603634 | CNVD |
Charcot | 16760730 | CNVD |
Mental retardation | 17901693 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
ovarian endometriomas | 16273235 | CNVD |
Smith-Magenis syndrome | 18923513 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Autism | 22492990 | CNVD |
Congenital abnormalities | 21549014 | CNVD |
Developmental delay | 18414209 | CNVD |
Developmental delay | 21549014 | CNVD |
Epilepsy | 20970697 | CNVD |
Mental retardation | 18414209 | CNVD |
Mental retardation | 21549014 | CNVD |
Smith-Magenis syndrome | 21981782 | CNVD |
Smith-Magenis syndrome | 20188345 | CNVD |
Smith-Magenis syndrome | 16775514 | CNVD |
Smith-Magenis syndrome | 22585170 | CNVD |
Smith-Magenis syndrome | 22241247 | CNVD |
Autism | 20970697 | CNVD |
Mental retardation | 19951919 | CNVD |
Potocki-Lupski syndrome | 21271655 | CNVD |
Potocki-lupski syndrome | 17357070 | CNVD |
Potocki-lupski syndrome | 20110824 | CNVD |
Potocki-lupski syndrome | 18923514 | CNVD |
Potocki-lupski syndrome | 22241247 | CNVD |
Potocki-lupski syndrome | 20188345 | CNVD |
Schizophrenia | 21399695 | CNVD |
Mental retardation | 16773131 | CNVD |
Adenocarcinoma | 19607727 | CNVD |
Squamous cell cancer | 19607727 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Charcot-marie-tooth disease | 22470819 | CNVD |
Neurofibromatosis | 22470819 | CNVD |
Neuropathy | 22470819 | CNVD |
Smith-Magenis syndrome | 18301319 | CNVD |
Smith-Magenis syndrome | 17357070 | CNVD |
Smith-Magenis syndrome | 18469339 | CNVD |
Smith-Magenis syndrome | 22241097 | CNVD |
Smith-Magenis syndrome | 22470819 | CNVD |
Tourette syndrome | 18923514 | CNVD |
Type 1 diabetes | 22470819 | CNVD |
Potocki-lupski syndrome | 18469339 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Neuropathy | 17597781 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 17015230 | CNVD |
Smith-Magenis syndrome | 17597781 | CNVD |
Potocki-lupski syndrome | 18059269 | CNVD |
Potocki-lupski syndrome | 17597781 | CNVD |
Mental retardation | 17847001 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 21509527 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 17142309 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:20572000-20581000 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
2 | chr17:20576600-20581000 | Enhancers | Primary B cells from peripheral blood | blood |
3 | chr17:20577200-20580000 | Weak transcription | Primary monocytes fromperipheralblood | blood |
4 | chr17:20579000-20583000 | Enhancers | GM12878-XiMat | blood |
5 | chr17:20579400-20583000 | Enhancers | Primary B cells from cord blood | blood |
6 | chr17:20579600-20580000 | Enhancers | Fetal Heart | heart |
7 | chr17:20579600-20581400 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
8 | chr17:20580000-20583000 | Enhancers | Primary monocytes fromperipheralblood | blood |
9 | chr17:20581000-20581400 | Flanking Active TSS | Primary B cells from peripheral blood | blood |
10 | chr17:20581000-20582800 | Enhancers | Monocytes-CD14+_RO01746 | blood |
11 | chr17:20581400-20585800 | Enhancers | Primary B cells from peripheral blood | blood |
12 | chr17:20582600-20582800 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
13 | chr17:20584600-20585000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
14 | chr17:20585000-20585800 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |